rs148983337
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_183075.3(CYP2U1):āc.992A>Gā(p.Asn331Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00102 in 1,614,126 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_183075.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP2U1 | NM_183075.3 | c.992A>G | p.Asn331Ser | missense_variant | 2/5 | ENST00000332884.11 | NP_898898.1 | |
CYP2U1 | XM_005262717.2 | c.1046A>G | p.Asn349Ser | missense_variant | 2/5 | XP_005262774.1 | ||
CYP2U1 | XM_005262720.2 | c.491-1905A>G | intron_variant | XP_005262777.1 | ||||
LOC107986298 | XR_001741784.2 | n.204+33249T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP2U1 | ENST00000332884.11 | c.992A>G | p.Asn331Ser | missense_variant | 2/5 | 1 | NM_183075.3 | ENSP00000333212.6 |
Frequencies
GnomAD3 genomes AF: 0.000979 AC: 149AN: 152220Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00123 AC: 309AN: 250826Hom.: 1 AF XY: 0.00144 AC XY: 195AN XY: 135618
GnomAD4 exome AF: 0.00103 AC: 1500AN: 1461788Hom.: 10 Cov.: 32 AF XY: 0.00111 AC XY: 805AN XY: 727196
GnomAD4 genome AF: 0.000978 AC: 149AN: 152338Hom.: 0 Cov.: 31 AF XY: 0.00101 AC XY: 75AN XY: 74490
ClinVar
Submissions by phenotype
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Hereditary spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Feb 18, 2021 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | CYP2U1: BP4 - |
CYP2U1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 01, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at